Lisbon, Portugal 23-26 April 2022
The Nanōmix eLab® system is a mobile, hand-held immunoassay system bringing diagnostic testing to new and expanded point-of-care locations.
Our initial product focus is to support critical patient care needs where rapid diagnostic information is needed to guide clinical intervention and improve patient outcome (Sepsis, Infectious Disease including SARS-CoV-2 and Acute Kidney Injury.)* The eLab system is designed for use in both hospital Emergency Departments and pre-hospital settings, including EMS and Urgent Care.
Nanōmix is currently expanding its product line through new global and regional distribution partnerships.
*The Nanōmix eLab® S1 Panel Cartridge for critical infections has received CE Mark. Not commercially available in the U.S.
COVID-19 Antigen Test cartridge for detection of SAR-CoV-2 antigen submitted for CE and FDA EUA. Not commercially available in the U.S.
Other assays in development.